{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:47:13Z","timestamp":1776926833647,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.semarthrit.2012.03.003","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T02:02:31Z","timestamp":1335405751000},"page":"127-130","source":"Crossref","is-referenced-by-count":19,"title":["Development of Leprosy in a Patient with Rheumatoid Arthritis During Treatment with Etanercept: A Case Report"],"prefix":"10.1016","volume":"42","author":[{"given":"Pablo","family":"Lluch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Urruticoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Lluch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda C.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Benet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Ene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2012.03.003_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/505430","article-title":"Tumor-necrosis-factor blockers: Differential effects on mycobacterial immunity","volume":"194","author":"Saliu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semarthrit.2012.03.003_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: The human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2012.03.003_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/qjmed\/94.4.207","article-title":"The diagnosis of leprosy is delayed in the United Kingdom","volume":"94","author":"Lockwood","year":"2001","journal-title":"QJM"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2012.03.003_bib4","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1086\/429994","article-title":"Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis","volume":"41","author":"Algood","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2012.03.003_bib5","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/429998","article-title":"Tumor necrosis factor and its blockade in granulomatous infections: Differential modes of action of infliximab and etanercept?","volume":"41","author":"Ehlers","year":"2005","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"10.1016\/j.semarthrit.2012.03.003_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2012.03.003_bib7","first-page":"40","article-title":"Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment","volume":"74","author":"Dinarello","year":"2005","journal-title":"J Rheumatol Suppl"},{"issue":"3","key":"10.1016\/j.semarthrit.2012.03.003_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2012.03.003_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","article-title":"Granulomatous infections due to tumor necrosis factor blockade: Correction","volume":"39","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2012.03.003_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/art.23815","article-title":"Type I reaction of Hansen's disease with exposure to adalimumab: A case report","volume":"59","author":"Oberstein","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2012.03.003_bib11","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/505222","article-title":"Development of leprosy and type 1 leprosy reactions after treatment with infliximab: A report of 2 cases","volume":"43","author":"Scollard","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2012.03.003_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-009-1140-0","article-title":"Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?","volume":"28","author":"Vilela Lopes","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2012.03.003_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S0482-50042010000300013","article-title":"Lepromatous leprosy associated with the use of anti-TNF \u03b1 therapy: Case report","volume":"50","author":"Freitas","year":"2010","journal-title":"Rev Bras Reumatol"},{"issue":"21","key":"10.1016\/j.semarthrit.2012.03.003_bib14","first-page":"201","article-title":"Vigilancia de la lepra","volume":"18","author":"Rodr\u00edguez","year":"2010","journal-title":"Cent Nac Epidemiol"},{"key":"10.1016\/j.semarthrit.2012.03.003_bib15","unstructured":"Summary information of infliximab(Remicade) characteristics from EMA. Consultable in http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000240\/WC500050888.pdf."},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2012.03.003_bib16","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/ard.2009.123885","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases","volume":"69","author":"Furst","year":"2010","journal-title":"Ann Rheum Dis 2009"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017212000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017212000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T23:20:47Z","timestamp":1561677647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017212000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0049017212000662"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2012.03.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}